Investigative and Clinical Urology

The Korean Urological Association (대한비뇨의학회)
권호 표지
DOI QR코드

DOI QR Code

Metastasis of Non-Muscle-Invasive Bladder Cancer Into the Thyroid Gland: A Literature Review Accompanied by a Rare Case

  • Tuncer, Murat (Department of Urology, Kartal Dr. Lutfi Kirdar Education and Research Hospital) ;
  • Faydaci, Gokhan (Department of Urology, Kartal Dr. Lutfi Kirdar Education and Research Hospital) ;
  • Altin, Gokhan (Department of Otorhinolaryngology, Kartal Dr. Lutfi Kirdar Education and Research Hospital) ;
  • Erdogan, Banu Atalay (Department of Otorhinolaryngology, Kartal Dr. Lutfi Kirdar Education and Research Hospital) ;
  • Kibar, Sermin (Department of Otorhinolaryngology, Kartal Dr. Lutfi Kirdar Education and Research Hospital) ;
  • Sanli, Arif (Department of Otorhinolaryngology, Kartal Dr. Lutfi Kirdar Education and Research Hospital) ;
  • Bilgici, Dilek (Department of Pathology, Kartal Dr. Lutfi Kirdar Education and Research Hospital)
  • Received : 2012.06.19
  • Accepted : 2012.07.31
  • Published : 2014.03.22
⟨ Previous Next ⟩

Abstract

Bladder cancer is the most prevalent malignancy of the urinary tract. About 90% of bladder cancers are urothelial carcinomas. Seventy percent of cases newly diagnosed are superficial diseases; roughly 30% of newly diagnosed cases are muscle-invasive metastatic diseases. Bladder urothelial carcinoma primarily metastasizes into regional lymph nodes and then into liver, lung, mediastinum, bone, and adrenal gland. In our case, non-muscle-invasive bladder cancer metastasized into the bone, mediastinum, iliac lymph node, and adrenal and thyroid glands. This is the first reported case in the current literature in which urothelial carcinoma metastasized into the thyroid gland.

Keywords

References

  1. Ferlay J, Randi G, Bosetti C, Levi F, Negri E, Boyle P, et al. Declining mortality from bladder cancer in Europe. BJU Int 2008;101:11-9.
  2. Dougherty DW, Gonsorcik VK, Harpster LE, Trussell JC, Drabick JJ. Superficial bladder cancer metastatic to the lungs: two case reports and review of the literature. Urology 2009;73:210.e3-5.
  3. Alexander PW, Sanders C, Nath H. Cavitary pulmonary metastases in transitional cell carcinoma of urinary bladder. AJR Am J Roentgenol 1990;154:493-4. https://doi.org/10.2214/ajr.154.3.2106210
  4. Nishiyama H, Habuchi T, Watanabe J, Teramukai S, Tada H, Ono Y, et al. Clinical outcome of a large-scale multi-institutional retrospective study for locally advanced bladder cancer: a survey including 1131 patients treated during 1990-2000 in Japan. Eur Urol 2004;45:176-81. https://doi.org/10.1016/j.eururo.2003.09.011
  5. Gwynn ES, Clark PE. Bladder cancer. Curr Opin Oncol 2006;18:277-83. https://doi.org/10.1097/01.cco.0000219258.75961.1a
  6. Kardar AH, Lindstedt EM, Tulbah AM, Bazarbashi SN, al Suhaibani HS. Metastatic transitional cell carcinoma of the ovary from superficial bladder tumour. Scand J Urol Nephrol 1998;32:73-6. https://doi.org/10.1080/003655998750014774
  7. Dutta SC, Smith JA Jr, Shappell SB, Coffey CS, Chang SS, Cookson MS. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. J Urol 2001;166:490-3. https://doi.org/10.1016/S0022-5347(05)65969-1
  8. Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Bohle A, Palou-Redorta J, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol 2011;59:997-1008. https://doi.org/10.1016/j.eururo.2011.03.017
  9. Puente S, Velasco A, Gallel P, Pallares J, Perez-Ruiz L, Ros S, et al. Metastatic small cell carcinoma to the thyroid gland: a pathologic and molecular study demonstrating the origin in the urinary bladder. Endocr Pathol 2008;19:190-6. https://doi.org/10.1007/s12022-008-9024-4
  10. Schroder S, Wodzynski A, Padberg B. Cytokeratin expression of benign and malignant epithelial thyroid gland tumors: an immunohistologic study of 154 neoplasms using 8 different monoclonal cytokeratin antibodies. Pathologe 1996;17:425-32. https://doi.org/10.1007/s002920050181

Cited by

  1. Diabetes is an Important Risk Factor for Metastasis in Non-Muscle-Invasive Bladder Cancer vol.17, pp.1, 2014, https://doi.org/10.7314/apjcp.2016.17.1.105